囊性纤维化-母体健康专项服务中的妊娠产科与新生儿结局:一项回顾性研究
该回顾性研究分析了2020年9月至2025年2月伦敦某成人囊性纤维化(CF)服务中心的53例囊性纤维化女性(fwCF)共67次妊娠、69名婴儿的母体、产科及新生儿结局。81%妊娠报告使用ETI治疗,无死产及母儿死亡,但无CF糖尿病者中57%发生妊娠期糖尿病,31%妊娠因感染性肺急性加重住院。结论认为在专项CF-母体健康服务中,ETI治疗引入后结局有所改善。
要点
- 53例fwCF完成67次妊娠,共69名婴儿出生,无死产、新生儿或母体死亡。
- 81%妊娠报告使用ETI治疗;无CF糖尿病者中57%发生妊娠期糖尿病。
- 31%妊娠因感染性肺急性加重住院治疗,45%妊娠经阴道分娩,78%婴儿足月出生。
核心结论
- 在专项CF-母体健康服务中,ETI治疗引入后fwCF的母体、产科及新生儿结局有所改善。
研究设计与样本
- 回顾性数据审查,来源为2020年9月至2025年2月期间CF-母体健康服务的数据。
- 研究场所为英国伦敦一家大型成人CF服务中心,样本为就诊于Royal Brompton Hospital CF服务的妊娠fwCF。
- 共53例fwCF完成67次妊娠,69名婴儿出生。
主要发现
- 无死产、新生儿死亡或母体死亡。
- 81%妊娠报告使用ETI治疗。
- 无CF糖尿病的fwCF中57%发生妊娠期糖尿病。
- 31%妊娠因感染性肺急性加重需住院治疗。
- 45%妊娠经阴道分娩,78%婴儿足月出生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A comprehensive review of maternal, obstetric and neonatal outcomes in pregnancies in females with cystic fibrosis (fwCF) following the introduction of Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy in a novel, dedicated CF-Maternal Health service. DESIGN: Retrospective data review from a CF-Maternal Health service between September 2020 and February 2025. SETTING: A large adult-CF service in London, UK. POPULATION OR SAMPLE: Pregnant fwCF attending the Royal Brompton Hospital CF Service. METHODS: Review of CF-Maternal Health service data. MAIN OUTCOME MEASURES: Maternal, obstetric and neonatal outcomes. RESULTS: Fifty-three fwCF completed 67 pregnancies, with 69 infants born. There were no stillbirths, neonatal or maternal deaths. ETI-therapy was reported in 81% of pregnancies. In fwCF without CF-Diabetes, 57% developed gestational diabetes. Hospital admission to treat an infective pulmonary exacerbation was required in 31% of pregnancies. Forty-five percent of pregnancies delivered vaginally; 78% of babies were born at term. A major congenital abnormality was diagnosed in 4% of infants. Baseline lung-function correlated positively with birth-weight and gestation at birth. CONCLUSIONS: FwCF have improved maternal, obstetric and neonatal outcomes since the introduction of ETI-therapy, within a dedicated CF-Maternal Health service.
引用
- Scott R, Downes A, Weitnauer L, et al. Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis-Maternal Health Service: A Retrospective Study. BJOG. 2025. PMID: 41208508. doi:10.1111/1471-0528.70075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。